Literature DB >> 31036459

Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design.

Michael Haber1, Benjamin A Lopman2, Jacqueline E Tate3, Meng Shi4, Umesh D Parashar3.   

Abstract

BACKGROUND: Rotavirus is the leading cause of severe diarrhea among children worldwide, and vaccines can reduce morbidity and mortality by 50-98%. The test-negative control (TNC) study design is increasingly used for evaluating the effectiveness of vaccines against rotavirus and other vaccine-preventable diseases. In this study design, symptomatic patients who seek medical care are tested for the pathogen of interest. Those who test positive (negative) are classified as cases (controls).
METHODS: We use a probability model to evaluate the bias of estimates of rotavirus vaccine effectiveness (VE) against rotavirus diarrhea resulting in hospitalization in the presence of possible confounding and selection biases due to differences in the propensity of seeking medical care (PSMC) between vaccinated and unvaccinated children.
RESULTS: The TNC-based VE estimate corrects for confounding bias when the confounder's effects on the probabilities of rotavirus and non-rotavirus related hospitalizations are equal. If this condition is not met, then the estimated VE may be substantially biased. The bias is more severe in low-income countries, where VE is known to be lower. Under our model, differences in PSMC between vaccinated and unvaccinated children do not result in selection bias when the TNC study design is used.
CONCLUSIONS: In practice, one can expect the association of PSMC (or other potential confounders) with the probabilities of rotavirus and non-rotavirus related hospitalization to be similar, in which case the confounding effects will only result in small bias in the VE estimate from TNC studies. The results of this work, along with those of our previous paper, confirm the TNC design can be expected to provide reliable estimates of rotavirus VE in both high- and low-income countries.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Confounding bias; Probability models; Rotavirus vaccines; Selection bias; Test-negative design; Vaccine effectiveness

Mesh:

Substances:

Year:  2019        PMID: 31036459      PMCID: PMC8864477          DOI: 10.1016/j.vaccine.2019.04.065

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies.

Authors:  Jacqueline E Tate; Manish M Patel; Margaret M Cortese; Daniel C Payne; Benjamin A Lopman; Catherine Yen; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

Review 2.  Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.

Authors:  Edward A Belongia; Melissa D Simpson; Jennifer P King; Maria E Sundaram; Nicholas S Kelley; Michael T Osterholm; Huong Q McLean
Journal:  Lancet Infect Dis       Date:  2016-04-06       Impact factor: 25.071

Review 3.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Authors:  Sheena G Sullivan; Shuo Feng; Benjamin J Cowling
Journal:  Expert Rev Vaccines       Date:  2014-10-28       Impact factor: 5.217

4.  The impact of selection bias on vaccine effectiveness estimates from test-negative studies.

Authors:  Michael L Jackson; C Hallie Phillips; Joyce Benoit; Erika Kiniry; Lawrence Madziwa; Jennifer C Nelson; Lisa A Jackson
Journal:  Vaccine       Date:  2017-12-15       Impact factor: 3.641

5.  A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness.

Authors:  Michael Haber; Benjamin A Lopman; Jacqueline E Tate; Meng Shi; Umesh D Parashar
Journal:  Vaccine       Date:  2018-07-03       Impact factor: 3.641

6.  Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

Authors:  D M Skowronski; C Masaro; T L Kwindt; A Mak; M Petric; Y Li; R Sebastian; M Chong; T Tam; G De Serres
Journal:  Vaccine       Date:  2006-10-16       Impact factor: 3.641

7.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

8.  Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design.

Authors:  Lauren M Schwartz; M Elizabeth Halloran; Ali Rowhani-Rahbar; Kathleen M Neuzil; John C Victor
Journal:  Vaccine       Date:  2016-11-18       Impact factor: 3.641

9.  Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016.

Authors:  Jason M Mwenda; Rachel M Burke; Keith Shaba; Richard Mihigo; Mable Carole Tevi-Benissan; Mutale Mumba; Joseph Nsiari-Muzeyi Biey; Dah Cheikh; Alain Poy MSc; Felicitas R Zawaira; Negar Aliabadi; Jacqueline E Tate; Terri Hyde; Adam L Cohen; Umesh D Parashar
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-11-03       Impact factor: 17.586

10.  A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.

Authors:  Meng Shi; Qian An; Kylie E C Ainslie; Michael Haber; Walter A Orenstein
Journal:  BMC Infect Dis       Date:  2017-12-08       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.